Outcome of pregnancy in women with congenital heart disease

Cardiology in the Young

Volumn 9, Issue 1, 1999, Pages 88-96

  Schmaltz, A A ^a   Neudorf, U ^a   Winkler, U H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Anticoagulation; Congenital heart disease; Fetal risk; Genetic risk; Maternal risk; Pregnancy

Indexed keywords

CONGENITAL HEART MALFORMATION; FEMALE; HIGH RISK PREGNANCY; HUMAN; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; REVIEW; RISK ASSESSMENT;

FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; RISK ASSESSMENT;

EID: 0032602702     PISSN: 10479511     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1047951100007496     Document Type: Article

References (68)

1. McFaul PB, Dornan JC, Lamki H, Boyle D. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obst Gyn 1988; 95: 861-867.
2. Wada H, Chiba Y, Murakami M, Kawaguchi H, Kobayashi H, Kanzaki T. Analysis of maternal and fetal risk in 594 pregnancies with heart disease. Nippon Sanka Fujinka Gakkai Zasshi 1996; 48: 5-262.
3. Mühler EG, Franke A, Lepper W, Grabitz RG, Hermann G, Klues HG, Messmer BJ, Hanrath P, v Bernuth G. Die Betreuung von Adoleszenten und Erwachsenen mit angeborenem Herzfehler: 3 Jahre Erfahrungen mit einer interdisziplinären Sprechstunde. Z Kardiol 1995; 84: 532-541.
4. Hennessy TG, MacDonald D, Hennessy MS, Maguire M, Blake S, McCann HA, Sugrue DD. Serial changes in cardiac output during normal pregnancy: a Doppler ultrasound study. Eur J Obstet Gynecol Reprod Biol 1996; 70: 117-122.
5. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J 1992; 68: 540-543.
6. Robson SC, Dunlop W, Moore M, Hunter S. Combined Doppler and echocardiographic measurement of cardiac output: theory and application in pregnancy. Br J Obstet Gynaecol 1987; 94: 1014-1027.
7. Robson SC, Hunter S, Boys RJ, Dunlop W. Hemodynamic changes during twin pregnancy. A Doppler and M-mode echocardiographic study. Am J Obstet Gynecol 1985; 161: 1273-1278.
8. Perloff JK: Pregnancy in congenital heart disease. The mother and the fetus. In Perloff, JK and Child JS: Congenital Heart Disease in Adults. WB Saunders, Philadelphia, 1991, pp 124-140.
9. Szekely P, Snaith L. Heart disease and pregnancy. Churchill Livingstone, Edinburgh, 1974.
10. Chia YT, Yeoh SC, Viegas OA, Lim M, Ratnam SS. Maternal congenital heart disease and pregnancy outcome. J Obstet Gynaecol Res 1996; 22: 185-191.
11. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanoctic congenital heart disease. Outcome of mother and fetus. Circulation 1994; 89: 2673-2676.
12. Presbitero P, Rabajoli F, Somerville J. Pregnancy in patients with congenital heart disease. Schweiz Med Wochenschr 1995; 1254: 311-315.
13. Elkayam U, Gleicher N. Cardiac problems in pregnancy: diagnosis and management of maternal and fetal disease.: Alan R Liss, Inc. New York 1982.
14. Pajszczyk-Kieszkiwicz T, Krzeminska-Pakula M, Kowalska-Koprek U, Zaslonka J, Zaslonka A. Pregnancy in women with valvular prostheses- follow-up observations. Z Kardiol 1986; 75, Suppl. 2: 308-311.
15. Kaemmerer H, Niesert S, Daniel WG, Lichtlen PR, Kallfelz HC. Schwangerschaft und angeborene Herzfehler. Z Kardiol 1994; 83: 208-214.
16. Perloff JK. Congenital heart disease in adults. Circulation 1991; 84: 1881-1890.
17. Whittemore R, Hobbins JC, Engle MA. Pregnancy and its outcome in women with and without surgical treatment of congenital heart disease. Am J Cardiol 1982; 50: 641-651.
18. Connolly HM, Warnes CA. Ebstein's anomaly: Outcome of pregnancy. J Am Coll Cardiol 1994; 23: 1194-1198.
19. Whittemore R, Anderson G, Orzalesi M, Driscoll S. Effects of maternal hypoxia on fetal and infant development (abstr). Pediatr Res 1971; 5: 426.
20. Presbitero P, Prever SB, Brusca A. Interventional cardiology in pregnancy. Eur Heart J 1996; 17: 182-188.
21. Loya YS, Desai DM, Sharma S. Mitral and pulmonary balloon valvotomy in pregnant patients. Indian Heart J 1993; 45: 57-59.
22. Perloff JK. Congenital heart disease and pregnancy. Clin Cardiol 1994; 17: 579-587.
23. Lao TT, Sermer M, MaGee L, Farine D, Colman JM. Congenital aortic stenosis and pregnancy - A reappraisal. Am J Obstet Gynecol 1993; 169: 540-545.
24. Angel JL, Chapman C, Knuppel RA, Morales WJ, Sims CJ. Percutaneous ballon aortic valvulopasty in pregnancy. Obstet Gynecol 1988; 72: 438-440.
25. McIvor RA. Percutaneous balloon aortic valvuloplasty during pregnancy. Int J Cardiol 1991; 32: 1-4.
26. Bernal JM, Miralles PJ. Cardiac surgery with cardiopulmonary bypass during pregnancy. Obstet Gynecol Surv 1986; 41: 1-6.
27. Oakley CM. Valvular disease in pregnancy. Curr Op Cardiol 1996; 11: 155-159.
28. Deal K, Wooley CF. Coarctation of the aorta und pregnancy. Ann Intern Med 1993; 78: 706-710.
29. Lipscomb KJ, Smith JC, Clarke B, Donnai P, Harris R. Outcome of pregnancy in women with Marfan's syndrome. Br J Obstet Gynaecol 1997; 104: 201-206.
30. Rossiter JP, Repke JT, Morales AJ, Murphy EA, Pyeritz RE. A prospective longitudinal evaluation of pregnancy in the Marfan syndrome. Am J Obstet Gynaecol 1995; 173: 1599-1606.
31. Presbitero P, D'Antonio P, Brusca A, Morea M. Prognosis of Pallet's Tetralogy after palliative operations: 10-25 year follow-up. Fed Cardiol 1983; 4: 175-182.
32. Neumayer U, Somerville J. Outcome of pregnancies in patients with complex pulmonary atresia. Heart 1997; 78: 16-21.
33. Avila WS, Grinberg M, Snitcowsky R, Faccioli R, Da Luz PL, Belotti G, Pileggi F. Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome. Eur Heart J 1995; 16: 460-464.
34. Brach-Prever S, Sheppard M, Somerville J. Fatal outcome of pregnancy in the Eisenmenger syndrome. Cardiol Young 1997; 7: 238-240.
35. Spinnato JA, Kraynack BJ, Cooper MW Eisenmenger's syndrome in pregnancy: Epidural anesthesia for elective Cesarean section. N Engl J Med 1981; 304: 1215-1217.
36. Young D, Mark H. Fate of the patient with the Eisenmenger syndrome. Am J Cardiol 1971; 28: 658-669.
37. Nolan FA, Engle MA, Diaz S. The pregnant adolescent with heart disease. In: Julian DG, Wenger NK (eds.): Cardiac problems of the adolescent and young adult. Butterworths, London, 1985, pp 213-231.
38. Ralstin JH, Dunn M. Pregnancies after surgical correction of tetralogy of Fallot. J Am Med Ass 1976; 235: 2627.
39. Clarkson PM, Wilson NJ, Neutze JM, North RA, Calder AL, Boyes-Barratt BG. Outcome of pregnancy after the Mustard operation for transposition of the great arteries with intact ventricular septum. J Am Coll Cardiol 1994; 24: 190-193.
40. Jahangiri M, Shore D, Kakkar V, Lincoln Ch, Shinebourne E. Coagulation factor abnormalities after the Fontan procedure and its modifications. J Thorac Cardiovasc Surg 1997; 113: 989-993.
41. Jonas RA. Intracardiac thrombus after the fontan procedure. J Thorac Cardiovasc Surg 1995; 110: 1502-1503.
42. Kaulitz R, Luhmer I, Bergmann F, Rodeck B, Hausdorf G. Sequelae after modified Fontan operation: postoperative hemodynamic data and organ function. Heart 1997; 78: 154-159.
43. Driscoll DJ, Offord KP, Feldt RH, Schaff HV Puga FJ, Danielson GK. Five- to fifteen-year follow-up after Fontan operation. Circulation 1992; 85: 469-496.
44. Girod DA, Fontan F, Deville C, Ottenkamp J, Choussat A. Long-term results after the Fontan operation for tricuspid atresia. Circulation 1987; 75: 605-610.
45. Canobbio MM, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol 1996; 28: 763-767.
46. Osmers R, Osmers M, Bartmus D, Ruscheswki W, Kuhn W. Ausgetragene Schwangerschaft nach maternaler Fontan'scher Operation bei univentrikulärem Herzen. Z Geburtsh Neonatol 1995; 199: 195-198.
47. Elkayam U. Anticoagulation in pregnant women with prosthetic heart valves: a double jeopardy. J Am Coll Cardiol 1996; 27: 1704-1706.
48. Yuh-Jer Shen A, Mansukhani PW. Is pregnancy contraindicated after cardiac transplantation? A case report and literature review. Int J Cardiol 1997; 60: 151-156.
49. Wagoner LE, Taylor DO, Olsen SL. Immunosuppressive therapy, management, and outcome of heart transplant recipients during pregnancy. J. Heart Lung Transplant 1993; 13: 993-1000.
50. Oakley CM. Anticoagulation and pregnancy. Eur Heart J 1995; 16: 1317-1319.
51. Badduke BR, Jamieson WRE, Miyagishima RT, Munro AI, Gerein AN, MacNab J, Tyers GFO. Pregnancy and childbearing in a population with biologic valvular prostheses. J Thorac Cardiovasc Surg 1991; 102: 179-186.
52. Hanania G, Thomas D, Michel PL, Garbarz E, Ages C, Millaire Acar J. Pregnancy and prosthetic heart valves: a French cooperative retrospective study of 155 cases. Eur Heart J 1994; 15: 1651-1658.
53. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994; 71: 196-210.
54. Dore A, Somerville J. Pregnancy in patients with pulmonalry autograft valve. Eur Heart J 1997; 18: 1659-1662.
55. Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants, and pregnancy. Circulation 1984; 70 (suppl I): 1-169.
56. Ginsberg JS, Hirsch J, Turner DC, Levine MN, Burrows R. Risks to the fetus of anticoagulant therapy during pregnancy. Thromb Haemost 1989; 61: 197-203.
57. Gohlke-Bärwolf C, Acar J, Oakley C, Butchard E, Burckhardt D, Bodnar E, Hall R, Delahaye J-P, Horstkotte D, Kremer R, Krayenbühl HP, Krzeminska-Pakula M, Samama M. Guidelines for prevention of thromboembolic events in valvular heart disease. Eur Heart J 1995; 16: 1320-1330.
58. Iturbe-Alessio I, Fonseca M, del C Mutchinik O, Santos MA, Zajarias A, Salazar E. Risks of anticoagulant therapy in pregnant women with artificial heart valves. N Engl J Med 1986; 315: 1390-1393.
59. Salazar E, Izagurine R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve protheses. J Am Coll Cardiol 1996; 17: 1698-713.
60. Leonard H, O'Sullivan JJ, Hunter S. Family planning requirements in the adult congenital heart disease clinic. Heart 1996; 76: 60-62.
61. Swan L, Hillis WS, Cameron A. Family planning requirements of adults with congenital heart disease. Heart 1997; 78: 9-11.
62. Winkler UH: Thromboembolierisiko, hormonelle Kontrazeption und Östrogensubstitution. Gynäkologe 1997; 30: 521-526.
63. Nora JJ. From generational studies to a multilevel genetic-environmental interaction. J Am Coll Cardiol 1994; 23: 1468-1471.
64. Driscoll DJ, Michel W, Gersony WM, Hayes CJ, Keane JF, Kidd L, Pieroni DR, Rings LJ, Wolfe RR, Weidmann WH. Occurrence risk for congenital heart defects in relatives of patients with aortic stenosis, pulmonary stenosis, or ventricular septal defect. Circulation 1993; 87 [suppl I]: I-114-I-120.
65. Whittemore R, Wells JA, Castellsague X. A second-generation study of 427 probands with congenital heart defects and their 837 children. J Am Coll Cardiol 1994; 23: 1459-67.
66. Nora JJ, Nora AH. Maternal transmission of congenital heart diseases: new reccurrence risk figures and the questions of cytoplasmatic inheritance and vulnerability to teratogens. Am J Cardiol 1987; 59: 459-463.
67. Clark SL, Cotton DB, Lee W, Bishop C, Hill T, South-wick J, Pivarnik J, Spillman T, DeVore DG, Phelan J, Hankins GDV, Benedetti TJ, Tolley D. Central hemodynamic assessement of normal human pregnancy. Am J Obstet Gynecol 1989; 161: 1439-1442.
68. Longo LD. Maternal blood volume and cardiac output during pregnancy: a hypothesis of endocrinologic control. Am J Physiol 1983; 245: 720-729.